DR. KATHERINE N WEILBAECHER, MD
Osteopathic Medicine in Saint Louis, MO
License number
Missouri 2000166707
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
4921 Floor SUITE A, Saint Louis, MO 63110
Phone
(314) 362-5677
(314) 362-7086 (Fax)
(314) 362-7086 (Fax)
Personal information
See more information about KATHERINE N WEILBAECHER at radaris.comName
Address
Phone
536 Warren Ave, Saint Louis, MO 63130
7627 Wydown Blvd, Saint Louis, MO 63105
Professional information
Dr. Katherine N Weilbaecher, Saint Louis MO - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Siteman Cancer Center
4921 Parkview Pl #Suite A/B/C, Saint Louis 63110
(314) 362-7578 (Phone)
4921 Parkview Pl #Suite A/B/C, Saint Louis 63110
(314) 362-7578 (Phone)
Certifications:
Internal Medicine, 1995, Medical Oncology, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Siteman Cancer Center
4921 Parkview Pl #Suite A/B/C, Saint Louis 63110
Barnes - Jewish West County Hospital
12634 Olive Blvd, Saint Louis 63141
Barnes Jewish Hospital
1 Barnes Jewish Hospital Plz, Saint Louis 63110
4921 Parkview Pl #Suite A/B/C, Saint Louis 63110
Barnes - Jewish West County Hospital
12634 Olive Blvd, Saint Louis 63141
Barnes Jewish Hospital
1 Barnes Jewish Hospital Plz, Saint Louis 63110
Education:
Medical School
Stanford University
Graduated: 1992
Stanford University Hospital
Dana Farber Cancer Inst
Stanford University
Graduated: 1992
Stanford University Hospital
Dana Farber Cancer Inst
Katherine N Weilbaecher, Saint Louis MO
Specialties:
Internal Medicine, Medical Oncology
Work:
Washington University at St. Louis
4921 Parkview Pl, Saint Louis, MO 63110 Washington University at St. Louis
660 S Euclid Ave, Saint Louis, MO 63110
4921 Parkview Pl, Saint Louis, MO 63110 Washington University at St. Louis
660 S Euclid Ave, Saint Louis, MO 63110
Education:
Stanford University (1992)
Methods Of Treating, Preventing And Inhibiting Cancer Metastasis And Tumor Formation
US Patent:
2007018, Aug 9, 2007
Filed:
Jul 15, 2004
Appl. No.:
10/564945
Inventors:
Katherine Weilbaecher - University City MO, US
Suzanne Bakewell - Philadelphia PA, US
Suzanne Bakewell - Philadelphia PA, US
International Classification:
A61K 31/55, A61K 31/4747, A61K 31/407, A61K 31/397
US Classification:
514210160, 514212020, 514278000, 514409000
Abstract:
Disclosed are methods for treating, preventing or inhibiting tumor cell metastasis, tumor cell formation, and destroying tumors in a subject comprising administering to the subject in need of such therapy a therapeutically effective amount of an activated aIIbβ3 receptor antagonist and by transplanting affected bone marrow with β3−/−marrow or controlling the expression of β3 integrin in vitro or in vivo. The activated allbβ3 receptor antagonist is preferably a spiro compound.